Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome

Journal of Cardiovascular Electrophysiology

Volumn 17, Issue 8, 2006, Pages 857-864

  Meregalli, Paola G ^a   Ruijter, Jan M ^a   Hofman, Nynke ^a   Bezzina, Connie R ^a   Wilde, Arthur A M ^a   Tan, Hanno L ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Arrhythmia; Brugada syndrome; Electrocardiogram; Flecainide; Genetics; Ion channels

Indexed keywords

FLECAINIDE; SODIUM CHANNEL VOLTAGE GATED TYPE 5 ALPHA; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

ADULT; AMPLITUDE MODULATION; ARTICLE; BRUGADA SYNDROME; CALCULATION; CLINICAL OBSERVATION; CONSENSUS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG SAFETY; ELECTROCARDIOGRAM; FAMILY; FEMALE; FUNCTIONAL MORPHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; OUTCOMES RESEARCH; P WAVE; PREDICTION; PRIORITY JOURNAL; QRS COMPLEX; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ADULT; BRUGADA SYNDROME; ELECTROCARDIOGRAPHY; FEMALE; FLECAINIDE; HUMANS; MALE; MIDDLE AGED; MUSCLE PROTEINS; MUTATION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SODIUM CHANNELS;

EID: 33746061309     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2006.00531.x     Document Type: Article

References (37)

1. Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, Hauer RN, Kass RS, Nademanee K, Priori SG, Towbin JA: Proposed diagnostic criteria for the Brugada syndrome: Consensus report. Circulation 2002;106:2514-2519.
2. Brugada J, Brugada R, Brugada P: Right bundle-branch block and ST-segment elevation in leads V1 through V3: A marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998;97:457-460.
3. Meregalli PG, Wilde AAM, Tan HL: Pathophysiological mechanisms of Brugada syndrome: Depolarization disorder, repolarization disorder or more? Cardiovasc Res 2005;67:367-378.
4. Martini B, Nava A, Thiene G, Buja GF, Canciani B, Scognamiglio R, Daliento L, Dalla VS: Ventricular fibrillation without apparent heart disease: Description of six cases. Am Heart J 1989;118:1203-1209.
5. Corrado D, Basso C, Buja G, Nava A, Rossi L, Thiene G: Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people. Circulation 2001;103:710-717.
6. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A: Brugada syndrome: report of the second consensus conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;111:659-670.
7. Wang Q, Li Z, Shen J, Keating MT: Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics 1996;34:9-16.
8. Priori SG, Napolitano C, Gasparini M, Pappone C, Della BP, Giordano U, Bloise R, Giustetto C, De Nardis R, Grillo M, Ronchetti E, Faggiano G, Nastoli J: Natural history of Brugada syndrome: Insights for risk stratification and management. Circulation 2002;105:1342-1347.
9. Moric E, Herbert E, Trusz-Gluza M, Filipecki A, Mazurek U, Wilczok T: The implications of genetic mutations in the sodium channel gene (SCN5A). Europace 2003;5:325-334.
10. Bezzina CR, Rook MB, Wilde AA: Cardiac sodium channel and inherited arrhythmia syndromes. Cardiovasc Res 2001;49:257-271.
11. Mohler PJ, Rivolta I, Napolitano C, Lemaillet G, Lambert S, Priori SG, Bennett V: Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. Proc Natl Acad Sci USA 2004;101:17533-17538.
12. Tan HL, Bezzina CR, Smits JP, Verkerk AO, Wilde AA: Genetic control of sodium channel function. Cardiovasc Res 2003;57:961-973.
13. Tukkie R, Sogaard P, Vleugels J, de Groot IK, Wilde AA, Tan HL: Delay in right ventricular activation contributes to Brugada syndrome. Circulation 2004;109:1272-1277.
14. Shimizu W, Antzelevitch C, Suyama K, Kurita T, Taguchi A, Aihara N, Takaki H, Sunagawa K, Kamakura S: Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2000;11:1320-1329.
15. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S: Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996;27:1061-1070.
16. Brugada R, Brugada J, Antzelevitch C, Kirsch GE, Potenza D, Towbin JA, Brugada P: Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000;101:510-515.
17. Priori SG, Napolitano C, Gasparini M, Pappone C, Della BP, Brignole M, Giordano U, Giovannini T, Menozzi C, Bloise R, Crotti L, Terreni L, Schwartz PJ: Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. Circulation 2000;102:2509-2515.
18. Hong K, Brugada J, Oliva A, Berruezo-Sanchez A, Potenza D, Pollevick GD, Guerchicoff A, Matsuo K, Burashnikov E, Dumaine R, Towbin JA, Nesterenko V, Brugada P, Antzelevitch C, Brugada R: Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation 2004;110:3023-3027.
19. Wolpert C, Echternach C, Veltmann C, Antzelevitch C, Thomas GP, Spehl S, Streitner F, Kuschyk J, Schimpf R, Haase KK, Borggrefe M: Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome. Heart Rhythm 2005;2:254-260.
20. Brugada P, Brugada R, Brugada J: Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation 2005;112:279-292.
21. Priori SG, Napolitano C: Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation 2005;112:279-292.
22. Rolf S, Bruns HJ, Wichter T, Kirchhof P, Ribbing M, Wasmer K, Paul M, Breithardt G, Haverkamp W, Eckardt L: The ajmaline challenge in Brugada syndrome: Diagnostic impact, safety, and recommended protocol. Eur Heart J 2003;24:1104-1112.
23. Gasparini M, Priori SG, Mantica M, Napolitano C, Galimberti P, Ceriotti C, Simonini S: Flecainide test in Brugada syndrome: A reproducible but risky tool. Pacing Clin Electrophysiol 2003;26:338-341.
24. Morita H, Morita ST, Nagase S, Banba K, Nishii N, Tani Y, Watanabe A, Nakamura K, Kusano KF, Emori T, Matsubara H, Hina K, Kita T, Ohe T: Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. J Am Coll Cardiol 2003;42:1624-1631.
25. Smits JP, Eckardt L, Probst V, Bezzina CR, Schott JJ, Remme CA, Haverkamp W, Breithardt G, Escande D, Schulze-Bahr E, LeMarec H, Wilde AA: Genotype-phenotype relationship in Brugada syndrome: Electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 2002;40:350-356.
26. Schulze-Bahr E, Eckardt L, Breithardt G, Seidl K, Wichter T, Wolpert C, Borggrefe M, Haverkamp W: Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: Different incidences in familial and sporadic disease. Hum Mutat 2003;21:651-652.
27. Shimizu W, Matsuo K, Takagi M, Tanabe Y, Aiba T, Taguchi A, Suyama K, Kurita T, Aihara N, Kamakura S: Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: Clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J Cardiovasc Electrophysiol 2000;11:396-404.
28. Sangwatanaroj S, Prechawat S, Sunsaneewitayakul B, Sitthisook S, Tosukhowong P, Tungsanga K: New electrocardiographic leads and the procainamide test for the detection of the Brugada sign in sudden unexplained death syndrome survivors and their relatives. Eur Heart J 2001;22:2290-2296.
29. Hisamatsu K, Morita H, Fukushima KK, Takenaka S, Nagase S, Nakamura K, Emori T, Ohe T: Evaluation of the usefulness of recording the ECG in the 3rd intercostal space and prevalence of Brugada-type ECG in accordance with recently established electrocardiographic criteria. Circ J 2004;68:135-138.
30. Pitzalis MV, Anaclerio M, Iacoviello M, Forleo C, Guida P, Troccoli R, Massari F, Mastropasqua F, Sorrentino S, Manghisi A, Rizzon P: QT-interval prolongation in right precordial leads: An additional electrocardiographic hallmark of Brugada syndrome. J Am Coll Cardiol 2003;42:1632-1637.
31. Bezzina C, Veldkamp MW, van den Berg MP, Postma AV, Rook MB, Viersma JW, van Langen IM, Tan-Sindhunata G, Bink-Boelkens MT, Der Hout AH, Mannens MM, Wilde AA: A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ Res 1999;85:1206-1213.
32. Tan HL, Bink-Boelkens MT, Bezzina CR, Viswanathan PC, Beaufort-Krol GC, van Tintelen PJ, van den Berg MP, Wilde AA, Balser JR: A sodium-channel mutation causes isolated cardiac conduction disease. Nature 2001;409:1043-1047.
33. Probst V, Allouis M, Sacher F, Pattier S, Babuty D, Mabo P, Mansourati J, Victor J, Nguyen JM, Schott JJ, Boisseau P, Escande D, Le Marec H: Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation. J Cardiovasc Electrophysiol 2006;17:270-275.
34. Smits JP, Koopmann TT, Wilders R, Veldkamp MW, Opthof T, Bhuiyan ZA, Mannens MM, Balser JR, Tan HL, Bezzina CR, Wilde AA: A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. J Mol Cell Cardiol 2005;38:969-981.
35. Veldkamp MW, Viswanathan PC, Bezzina C, Baartscheer A, Wilde AA, Balser JR: Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel. Circ Res 2000;86:E91-E97.
36. Matsuo K, Shimizu W, Kurita T, Inagaki M, Aihara N, Kamakura S: Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 1998;9:508-512.
37. Brugada J, Brugada R, Brugada P: Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003;108:3092-3096.